Batch Release & Batch Testing Site Support Services
Ensure pharmaceutical excellence by one batch at a time
Ensure pharmaceutical excellence by one batch at a time
We extend batch release and testing site support services to ensure your products meet high quality and compliance standards. We understand the importance of precise and timely batch release and testing, and are dedicated to supporting your success.
We provide GMP-certified importation, batch testing, and batch release services for human, veterinary, and investigational medicinal products. With multiple QPs and MIA holders, we can perform GMP batch testing and release for sterile, non-sterile, and biological medicinal products. Most of our clients are global manufacturers without mutual recognition agreements (MRA) importing their products within the developed countries. Batch testing is mandatory before batch release, and Zenovel’s integrated solution includes batch release for these manufacturers, allowing them to entrust their products until market release.
Our team of professionals brings extensive experience in pharmaceutical quality control and regulatory affairs.
We advanced testing and release services are powered by state-of-the-art laboratories and advanced technologies.
We work thoroughly with our clients to fully grasp their individual demands and then customise our offerings to fulfil those needs.
Our commitment to strict regulatory standards and integrity ensures the safety and effectiveness of our products in all our operations.
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S Certification) is
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.